Vitamin B2 Manufacturing Plant Project Report 2026: Cost Analysis, ROI, and Feasibility Insights

The manufacturing process is dominated by microbial fermentation using genetically engineered microbial strains, such as Ashbya gossypii or Bacillus strains, to convert glucose into riboflavin. The process generally involves strain cultivation, fermentation, biomass separation, recovery of riboflavin, purification, concentration, drying, and packaging.

The largest variable raw material cost comes from high-purity components used in the fermentation media, particularly glucose as the renewable carbon source. Glucose and other fermentation nutrients can together account for around 40–60% of raw material costs, depending on the fermentation yield, feed composition, and recovery efficiency.

Upstream processing equipment, particularly large automated stainless-steel fermenters or bioreactors, forms a major part of the investment. Fermentation, downstream recovery, purification, drying, and related process equipment can together account for around 40–55% of total plant CAPEX.

Manufacturing costs are primarily driven by the price of fermentation feedstocks, especially glucose and other high-purity media components. Other major cost factors include electricity and steam consumption, fermentation yield, aeration and agitation requirements, downstream purification, drying, labor, maintenance, and waste treatment.

Vitamin B2 manufacturing capacity is concentrated mainly in Europe and China. Major producers include BASF SE in Germany, DSM-Firmenich in the Netherlands, and several Chinese manufacturers such as Hubei Guangji Pharmaceutical, Hebei Shengxue Dacheng Pharmaceutical, and Hegno. China has a significant share of global riboflavin production, while Europe remains an important source of pharmaceutical and high-purity grades.

Vitamin B2 is available in food grade, feed grade, and pharmaceutical grade forms. High-purity riboflavin is used in food fortification, animal feed, dietary supplements, and pharmaceutical formulations. Pharmaceutical-grade material is manufactured under cGMP conditions and must meet applicable purity, assay, impurity, and microbiological specifications.

Manufacturing of pharmaceutical-grade Vitamin B2 requires compliance with applicable cGMP requirements and relevant pharmacopoeial standards. Depending on the target market and intended use, manufacturers may need to meet FDA or EMA requirements and provide supporting quality documentation, such as a Drug Master File (DMF) or equivalent regulatory documentation. Food and feed grades are subject to applicable food-safety, feed-safety, purity, and labeling requirements.